Accounting Profitability and the Political Process: The Case of R&D Accounting in the Pharmaceutical Industry

51 Pages Posted: 29 Nov 2014 Last revised: 21 Dec 2018

See all articles by Igor Goncharov

Igor Goncharov

Lancaster University - Department of Accounting and Finance

Jörg Mahlich

Heinrich Heine University Dusseldorf - Duesseldorf Institute for Competition Economics (DICE)

B. Burcin Yurtoglu

WHU - Otto Beisheim School of Management

Date Written: January 20, 2018

Abstract

Pharmaceutical firms frequently attract political attention due to their high accounting profitability. We study the U.S. pharmaceutical industry to test the two opposing views of how regulators use accounting information in the political process: The “public interest hypothesis” predicts that while regulators act in the public interest, they may find it costly to infer whether accounting profitability accurately captures monopolistic rents. The “private interest hypothesis” predicts that while regulators may know how accounting rules and their application distort profits, they choose to use unadjusted profits in regulation to achieve private benefits. We show that the abnormal profitability of pharmaceutical firms is a distortion introduced by the requirement for the immediate expensing of R&D costs and the effect of such expensing on reported accounting profits and book equity. We further show that the pharmaceutical firms’ high profitability triggers excessive regulatory scrutiny and increases regulation of the pharmaceutical industry. Although the high profitability has a greater impact on regulation when the public is more receptive to populist ideas, its effect is reduced when pharmaceutical firms increase their political contributions. Overall, our results both support the private interest hypothesis and help explain why regulators do not undo accounting distortions.

Keywords: Pharmaceutical Firms, ROE, Accounting for R&D, Regulation, Public Interest, Interest Groups

JEL Classification: L65, M41, G18

Suggested Citation

Goncharov, Igor and Mahlich, Jörg and Yurtoglu, B. Burcin, Accounting Profitability and the Political Process: The Case of R&D Accounting in the Pharmaceutical Industry (January 20, 2018). Available at SSRN: https://ssrn.com/abstract=2531467 or http://dx.doi.org/10.2139/ssrn.2531467

Igor Goncharov

Lancaster University - Department of Accounting and Finance ( email )

The Management School
Lancaster LA1 4YX
United Kingdom

Jörg Mahlich

Heinrich Heine University Dusseldorf - Duesseldorf Institute for Competition Economics (DICE) ( email )

Universitaetsstr. 1
Duesseldorf, NRW 40225
Germany

B. Burcin Yurtoglu (Contact Author)

WHU - Otto Beisheim School of Management ( email )

Chair of Corporate Finance
Burgplatz 2
Vallendar, 56179
Germany
+49 261 6509-721 (Phone)
+49 261 6509-729 (Fax)

HOME PAGE: http://www.whu.edu/forschung/fakultaet/finance-group/corporate-finance/

Register to save articles to
your library

Register

Paper statistics

Downloads
425
rank
65,150
Abstract Views
1,448
PlumX Metrics